You are here

Positive Results from an Investigational Open-Label Phase 3 Study in Children with CF Ages 1 to 2 Years

 

December 7, 2017

Today we announced positive results from an investigational open-label Phase 3 study in children with cystic fibrosis (CF) ages 1 to 2 years who have one of 10 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.